Phenotypic Assays

Summary of phenotypic assays used in Meta-Analysis

Assay ID Assay Class Molecules Active/Tested Assay Title View Enriched Targets
1663 antiplatelet 661|301072 MLPCN Platelet Activation -Dense Granule Release View
827 cancer_1 1659|136779 High Throughput Screen to Identify Compounds that Suppress the Growth of Cells with a Deletion of the PTEN Tumor Suppressor View
818 cancer_2 2052|136706 High Throughput Screen to Identify Compounds that Suppress the Growth of Human Colon Tumor Cells Lacking Oncogenic Beta Catenin Expression View
598 cancer_3 5142|80068 Human H69AR Lung Tumor Cell Growth Inhibition Assay - 86K Screen View
430 cancer_4 1123|61539 Fluorescent HTS Cytotoxicity/Cell viability assay (HPDE-C7 cells) View
431 cancer_5 1068|61593 Fluorescent HTS Cytotoxicity/Cell viability assay (HPDE-C7K cells) View
686971 cancer_7 7452|328241 qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line View
2717 cancer_8 3190|297011 Luminescence Cell-Based Primary HTS to Identify Inhibitors of Cancer Stem Cells View
904 p53_mutant 528|50471 qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53 Null Cells at the Nonpermissive Temperature View
902 p53_mutant 1909|118161 qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature View
903 p53_mutant 338|52488 qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53 Null Cells at the Permissive Temperature View
924 p53_mutant 1168|119940 qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature View